Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

Michael Crump; Tara Baetz; Stephen Couban; Andrew Belch; Deborah Marcellus; Kang Howson-Jan; Kevin Imrie; Robert Myers; Grenfell Adams; Keyue Ding; Nancy Paul; Lois Shepherd; Jose Iglesias; Ralph Meyer

doi:10.1002/cncr.20587

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

Michael Crump, Tara Baetz, Stephen Couban, Andrew Belch, Deborah Marcellus, Kang Howson-Jan, Kevin Imrie, Robert Myers, Grenfell Adams, Keyue Ding, Nancy Paul, Lois Shepherd, Jose Iglesias, Ralph Meyer

Research output: Contribution to journal › Article › peer-review

121 Citations (Scopus)

Original language	English
Pages (from-to)	1835-1842
Number of pages	8
Journal	Cancer
Volume	101
Issue number	8
DOIs	https://doi.org/10.1002/cncr.20587
Publication status	Published - Oct 15 2004
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncr.20587

Fingerprint

Dive into the research topics of 'Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)'. Together they form a unique fingerprint.

Cite this

Crump, M., Baetz, T., Couban, S., Belch, A., Marcellus, D., Howson-Jan, K., Imrie, K., Myers, R., Adams, G., Ding, K., Paul, N., Shepherd, L., Iglesias, J., & Meyer, R. (2004). Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). Cancer, 101(8), 1835-1842. https://doi.org/10.1002/cncr.20587

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). / Crump, Michael; Baetz, Tara; Couban, Stephen et al.
In: Cancer, Vol. 101, No. 8, 15.10.2004, p. 1835-1842.

Research output: Contribution to journal › Article › peer-review

Crump, M, Baetz, T, Couban, S, Belch, A, Marcellus, D, Howson-Jan, K, Imrie, K, Myers, R, Adams, G, Ding, K, Paul, N, Shepherd, L, Iglesias, J & Meyer, R 2004, 'Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)', Cancer, vol. 101, no. 8, pp. 1835-1842. https://doi.org/10.1002/cncr.20587

@article{54f9d62cef254f77b3dea7ac8515335a,

title = "Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)",

author = "Michael Crump and Tara Baetz and Stephen Couban and Andrew Belch and Deborah Marcellus and Kang Howson-Jan and Kevin Imrie and Robert Myers and Grenfell Adams and Keyue Ding and Nancy Paul and Lois Shepherd and Jose Iglesias and Ralph Meyer",

year = "2004",

month = oct,

day = "15",

doi = "10.1002/cncr.20587",

language = "English",

volume = "101",

pages = "1835--1842",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma

T2 - A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

AU - Crump, Michael

AU - Baetz, Tara

AU - Couban, Stephen

AU - Belch, Andrew

AU - Marcellus, Deborah

AU - Howson-Jan, Kang

AU - Imrie, Kevin

AU - Myers, Robert

AU - Adams, Grenfell

AU - Ding, Keyue

AU - Paul, Nancy

AU - Shepherd, Lois

AU - Iglesias, Jose

AU - Meyer, Ralph

PY - 2004/10/15

Y1 - 2004/10/15

UR - http://www.scopus.com/inward/record.url?scp=4744361815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744361815&partnerID=8YFLogxK

U2 - 10.1002/cncr.20587

DO - 10.1002/cncr.20587

M3 - Article

C2 - 15386331

AN - SCOPUS:4744361815

SN - 0008-543X

VL - 101

SP - 1835

EP - 1842

JO - Cancer

JF - Cancer

IS - 8

ER -

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this